Nature’s Sunshine Products, Inc., a leading manufacturer of high-quality herbal and nutritional supplements, recently reported financial results for the second quarter ended June 30, 2025.
Second Quarter 2025 Financial Summary vs. Same Year-Ago Quarter
Net sales were up 4% to $114.8 million compared to $110.6 million (up 2% in constant currency).
GAAP net income attributable to common shareholders was $5.3 million, or $0.28 per diluted common share, compared to $1.3 million, or $0.07 per diluted common share.
Adjusted EBITDA was up 8% to $11.3 million compared to $10.4 million.
Management Commentary
“We delivered another strong quarter, with net sales of $115 million and adjusted EBITDA of $11 million, up 4% and 8%, respectively, year-over-year,”
said Terrence Moorehead, CEO of Nature’s Sunshine.
“We’re particularly encouraged by the strength we continued to see in Japan and Central Europe, as well as sustained momentum in our digital business and auto ship program.
These results underscore the effectiveness of our global strategy and the progress we’ve made strengthening fundamentals in North America.
While the macroeconomic environment remains uncertain, we’re confident in the underlying health of the business and our ability to drive sustainable growth going forward.”
Second Quarter 2025 Financial Results
Net Sales by Operating Segment (Amounts in Thousands)
Three Months Ended June 30,
2025
2024
Percent
Change
Impact of
Currency
Exchange
Percent
Change
Excluding
Impact of
Currency
Asia
$
52,664
$
49,984
5.4
%
$
1,523
2.3
%
Europe
21,741
21,602
0.6
483
(1.6
)
North America
34,977
33,563
4.2
(25
)
4.3
Latin America and Other
5,368
5,402
(0.6
)
(184
)
2.8
$
114,750
$
110,551
3.8
%
$
1,797
2.2
%
Net sales in the second quarter increased 4%